Summary
Fibronectin is a dimeric glycoprotein with a molecular weight of 440,000. It is a soluble constituent of plasma and other body fluids and a fibrillar matrix protein of connective tissue. The two components are structurally similar and convertible. The possibility of multiple molecular interactions gives rise to a variety of biological functions. The regulation of cell growth and the reduced shedding of fibronectin from malignant cells raises the question as to whether fibronectin is valid as a tumour marker. In wound healing and chronic inflammation fibronectin serves as a scaffold for the formation of collagen. As opsonic protein it maintains reticuloendothelial function. Especially in shock, fibronectin may become the limiting factor of unspecific host defence mechanisms. The value of a substitution therapy will be discussed.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
Literatur
Alexander JW, McClellan MA, Ogle CK, Ogle JR (1976) Consumptive opsonopathy. Possible pathogenesis in lethal and opportunistic infection. Ann Surg 184:672–678
Alexander SS, Colonna G, Yamada KM, Pastan I, Edelhoch H (1978) Molecular properties of a major cell surface protein from chick embryo fibroblasts. J Biol Chem 253:5820–5824
Alitalo K, Hovi T, Vaheri A (1980) Fibronectin is produced by human macrophages. J Exp Med 151:602–613
Atherton BT, Hynes RO (1981) A difference between plasma and cellular fibronectin located with monoclonal antibodies. Cell 25:133–141
Balian G, Click EM, Crouch E, Davidson JM, Bornstein P (1979) Isolation of a collagen-binding fragment from fibronectin and cold-insoluble globulin. J Biol Chem 254:1429–1432
Bang NU, Hansen MS, Smith GF, Mosesson MW (1973) Properties of soluble fibrin polymers encountered in thrombotic states. Thromb Diath Haemorrh 56(Suppl):76–90
Bensusan HB, Koh TL, Henry KC, Murray BA, Culp LA (1978) Evidence that fibronectin is the collagen receptor on platelet membranes. Proc Natl Acad Sci USA 75:5864–5868
Birdwell CR, Gospodarowicz D, Nicolson GL (1978) Identification, localization, and role of fibronectin in cultured bovine endothelial cells. Proc Natl Acad Sci USA 75:3273–3277
Bleyl U, Klar E (1980) Der Abbau von löslichem und unlöslichem Fibrin durch das RES. Aus: Schimpf K (ed) Fibrinogen, Fibrin und Fibrinkleber. Nebenwirkungen der Therapie mit Gerinnungsfaktorenkonzentraten. Schattauer, Stuttgart New York, S 141–155
Blumenstock F, Saba TM, Weber P, Cho E (1976) Purification and biochemical characterization of a macrophage stimulating alpha-2-globulin opsonic protein. J Reticuloendothel Soc 19:157–172
Blumenstock F, Weber P, Saba TM (1977) Isolation and biochemical characterization of alpha-2-opsonic glycoprotein from rat serum. J Biol Chem 252:7156–7162
Blumenstock FA, Saba TM, Weber P, Laffin R (1978) Biochemical and immunological characterization of human opsonic alpha-2-SB glucoprotein: Its identity with cold insoluble globulin. J Biol Chem 253:4287–4291
Blumenstock F, Saba T, Weber T (1979) An affinity method for the rapid purification of opsonic alpha-2-SB glycoprotein from serum. Adv Shock Res 2:55–71
Boughton BJ, Simpson A (1982) Plasma fibronectin in acute leukaemia. Brit J Haematol 51:487–491
Bray BA (1978) Cold-insoluble globulin (fibronectin) in connective tissues of adult human lung and in trophoblast basement membrane. J Clin Invest 62:745–752
Bruhn HD, Heimburger N (1976) Factor VIII-related antigen and cold-insoluble globulin in leukaemias and carcinomas. Haemostasis 5:189–192
Carp H, Janoff H (1980) Potential mediator of inflammation: phagocyte-derived oxidants suppress the elastase-in-hibitory capacity of alpha1-proteinase inhibitor in vitro. J Clin Invest 66:987–995
Carsons S, Mosesson MW, Diamond HS (1981) Detection and quantitation of fibronectin in synovial fluid from patients with rheumatic disease. Arthritis Rheum 24:1261–1267
Chen AB, Mosesson MW (1977) An improved method for purification of the cold-insoluble globulin of human plasma (Clg). Anal Biochem 79:144–151
Chen AB, Amrani DL, Mosesson MW (1977) Heterogeneity of the cold-insoluble globulin of human plasma (Clg), a circulating cell surface protein. Biochem Biophys Acta 493:310–322
Chen LB, Maitland N, Gallimore PH, McDougall JK (1977) Detection of the large external transformation-sensitive protein on some epithelial cells. Exp Cell Res 106:39–46
Choate JJ, Mosher DF (1983) Fibronectin concentration in plasma of patients with breast cancer, colon cancer, and leukemia. Cancer 51:1142–1147
Clark RA, Quinn JH, Winn HJ, Lanigan JM, Dellepella P, Colvin RB (1982) Fibronectin is produced by blood vessels in response to injury. J Exp Med 156:646–651
Conrad A, Schürmann J, Kreutz FH (1978) Ausarbeitung einer Methode zur quantitativen Proteinbestimmung mit Hilfe eines Laser-Nephelometers im Routinelabor. J Clin Chem Clin Biochem 16:299–305
Cooper SM, Keyser AI, Beaulieu AD, Ruoslahti E, Nimni ME, Quismorio FP (1979) Increase in fibronectin in the deep dermis of involved skin in progressive systemic sclerosis. Arthritis Rheum 22:983–987
Crouch E, Balian G, Holbrook K, Duksin D, Bornstein P (1978) Amniotic fluid fibronectin. J Cell Biol 78:701–714
D'Ardenne HJ, Burns J, Sykes IC, Bennet MK (1983) Fibronectin and type III collagen in epithelial neoplasms of gastrointestinal tract and salivary gland. J Clin Pathol 36:756–763
Der CJ, Stanbridge EJ (1978) Lack of correlation between the decreased expression of cell surface LETS protein and tumorigenicity in human cell hybrids. Cell 15:1241–1251
Dessau W, Adelmann BC, Timpl R, Martin GR (1978) Identification of the sites in collagen alpha-chains that bind serum anti-gelatin factor (cold-insoluble globulin). Biochem J 169:55–59
Dessau W, Sasse J, Timpl R, Jilek F, von der Mark K (1978) Synthesis and extracellular deposition of fibronectin in chondrocyte cultures. Response to removal of extracellular cartilage matrix. J Cell Biology 79:342–355
Di Luzio NR, McNamee R, Miller EF, Pisano JC (1972) Macrophage recognition factor depletion after administration of particulate agents and leukemic cells. J Reticuloendothel Soc 12:314–323
Editorial (1983) Fibronectin and infection. Lancet 1:106–107
Edsall JT, Gilbert GA, Scheraga HA (1955) The non-clotting component of the human plasma fraction I-1 (“cold insoluble globulin”). J Am Chem Soc 77:157–161
Ehrlich MI, Krushell JS, Blumenstock FA, Kaplan JE (1981) Depression of phagocytosis by plasmin degradation products of plasma fibronectin. J Lab Clin Med 98:263–271
Engvall E, Ruoslahti E (1977) Binding of soluble form of fibroblast surface protein, fibronectin, to collagen. Int J Canc 20:1–5
Engvall E, Ruoslahti E, Miller EJ (1978) Affinity of fibronectin to collagens of different genetic types and to fibrinogen. J Exp Med 147:1584–1595
Filkins JP, Di Luzio NR (1966) Effects of gelatin and heparin on intravascular phagocytosis. J Reticuloendothel Soc 3:471–485
Filkins JP, Di Luzio NR (1968) Heparin protection in endotoxin shock. Am J Physiol 214:1074–1077
Fleischmayer R, Dessau W, Timpl R, Krieg T, Luderschmidt C, Wiestner M (1980) Immunofluorescence analysis of collagen, fibronectin, and basement membrane protein in scleroderma skin. J Invest Dermatol 75:270–274
Forkman B, Ganrot PO, Gennser G, Rannewick G (1972) Plasma protein pattern in recurrent cholestasis of pregnancy. Scand J Clin Lab Invest 29 (Suppl 124):89–96
Furcht LT, Mosher DF, Wendelschafer-Crabb G (1978) Effects of cell density and transformation on the formation of a fibronectin extracellular filamentous matrix on human fibroblasts. Cancer Res 38:4618–4623
Furcht LT, Mosher DF, Wendelschafer-Crabb G (1978) Immunocytochemical localization of fibronectin (LETS protein) on the surface of L 6 myoblasts: Light and electron microscopic studies. Cell 13:263–271
Fyrand O, Solum NO (1976) Studies on cold insoluble globulin in dermatological patients. I. Immunochemical quantitation in citrated plasma from patients with increased amounts of heparin precipitable fraction (HPF). Thromb Res 9:447–455
Fyrand O, Solum NO (1976) Heparin precipitable fraction (HPF) from dermatological patients. II. Studies on the non-clottable proteins. Identification of cold insoluble globulin as the main non-clottable component. Thromb Res 8:659–672
Fyrand O, Munthe E, Solum NO (1978) Studies on cold insoluble globulin. I. Concentrations in citrated plasma in rheumatic disorders. Ann Rheum Dis 37:347–350
Gahmberg GC, Kiehn D, Hakomori SI (1974) Changes in a surface-labelled galactoprotein and in glycolipid concentrations in cells transformed by a temperature-sensitive polyoma virus mutant. Nature 248:413–415
Ganrot PO (1972) Variation of the concentration of some plasma proteins in normal adults, in pregnant women and in newborns. Scand J Clin Lab Invest 29 (Suppl 124):83–88
Gans H (1966) Preservation of vascular patency as a function of reticuloendothelial clearance. Surg 60:1216–1223
Gans H, Lowman J (1967) Uptake of fibrin and fibrin degradation products by the isolated perfused rat liver. Blood 29:526–539
Gauss-Müller V, Kleinman HK, Martin GR, Schiffmann E (1980) Role of attachment factors and attractants in fibroblast chemotaxis. J Lab Clin Med 96:1071–1080
Ginsberg MH, Painter RG, Forsyth J, Birdwell CR, Plow EF (1980) Thrombin increases expression of fibronectin antigen on the platelet surface. Proc Natl Acad Sci USA 77:1049–1053
Goldman AS, Rudloff HB, McNamee R, Loose LD, Di Luzio NR (1973) Deficiency of plasma humoral recognition factor activity following burn injury. J Reticuloendothel Soc 15:193–198
Good RA, Thomas L (1952) Studies on the generalized Shwartzmann reaction. II. The production of bilateral cortical necrosis of the kidney by a single injection of bacterial toxin in rabbits previously treated with thorotrast or trypan blue. J Exp Med 96:625–641
Gressner AM, Wallraff P (1980) Der Einsatz der Lasernephelometrie zur Bestimmung und rechnergestützten Auswertung der Fibronektinkonzentration in verschiedenen Körperflüssigkeiten. J Clin Chem Clin Biochem 18:797–805
Gressner AM, Wallraff P (1981) Immunoturbidimetric measurement of cold insoluble globulin with reference to a laser nephelometric assay. J Clin Chem Clin Biochem 19:1213–1215
Gruber UF (1967) Intestinale Faktoren im Schock: Darmtoxine. Arch Klin Chir 319:909–925
Hahn L-HE, Yamada KM (1979) Isolation and biological characterization of active fragments of the adhesive glycoprotein fibronectin. Cell 18:1043–1051
Hahn L-HE, Yamada KM (1979) Identification and isolation of a collagen-binding fragment of the adhesive glycoprotein fibronectin. Proc Natl Acad Sci USA 76:1160–1163
Heideman M (1982) A shared effect of abscesses and non-viable tissue influencing the development of sepsis and acute respiratory distress syndrome. Acta Chir Scand Suppl 508:295–302
Höök M, Rubin K, Oldberg A, Ölbrinck B, Vaheri A (1977) Cold-insoluble globulin mediates the adhesion of rat liver cells to plastic petri dishes. Biochem Biophys Res Commun 79:726–733
Hörmann H (1982) Fibronectin — Mediator between cells and connective tissue. Klin Wochenschr 60:1265–1277
Hogg NM (1974) A comparison of membrane proteins of normal and transformed cells by lactoperoxidase labelling. Proc Natl Acad Sci 71:489–492
Hynes RO (1973) Alteration of cell surface proteins by viral transformation and by proteolysis. Proc Natl Acad Sci USA 70:3170–3174
Hynes RO (1974) Role of surface alterations in cell transformation: The importance of proteases and surface proteins. Cell 1:147–156
Hynes RO, Bye JM (1974) Density and cell cycle dependence of cell surface proteins in hamster fibroblasts. Cell 3:113–120
Hynes RO, Humphries KC (1974) Characterization of the external proteins of hamster fibroblasts. J Cell Biol 62:438–448
Hynes RO, Destree A (1977) Extensive disulfide bonding at the mammalian cell surface. Proc Natl Acad Sci USA 74:2855–2859
Hynes RO, Destree AT (1978) Relationships between fibronectin (LETS protein) and actin. Cell 15:875–886
Hynes RO, Ali IU, Destree AJ, Mautner V, Perkins ME, Senger DR, Wagner DD, Smith KK (1978) A large glycoprotein lost from the surfaces of transformed cells. Ann NY Acad Sci USA 312:317–342
Jaffe EA, Mosher DF (1978) Synthesis of fibronectin by cultured human endothelial cells. Ann NY Acad Sci 312:122–131
Janoff A, White R, Carp H, Harel S, Dearing R, Lee D (1979) Lung injury induced by leukocytic proteases. Am J Pathol 97:111–135
Jilek F, Hörmann H (1977) Cold-insoluble globulin. III. Cyanogen bromide and plasminolysis fragments containing a label introduced by transamidation. Hoppe-Seyler's Z Physiol Chem 358:1165–1168
Jilek F, Hörmann H (1978) Cold-insoluble globulin (fibronectin). IV. Affinity to soluble collagen of various types. Hoppe-Seyler's Z Physiol Chem 359:247–250
Jilek F, Hörmann H (1978) Fibronectin (cold-insoluble globulin). V. Mediation of fibrinmonomer binding to macrophages. Hoppe-Seyler's Z Physiol Chem 359:1603–1605
Jilek F, Hörmann H (1979) Fibronectin (cold-insoluble globulin). VI. Influence of heparin and hyaluronic acid on the binding of native collagen. Hoppe-Seyler's Z Physiol Chem 360:597–603
Kaplan JE, Saba TM (1976) Humoral deficiency and reticuloendothelial depression after traumatic shock. Am J Physiol 230:7–14
Kaplan JE, Saba TM, Cho E (1976) Serological modification of reticuloendothelial capacity and altered resistance to traumatic shock. Circ Shock 2:203–210
Kaplan JE, Saba TM (1978) Low grade intravascular coagulation and reticuloendothelial function. Am J Physiol 234:H323-H329
Kaplan JE, Snedecker PW (1980) Maintenance of fibrin solubility by plasma fibronectin. J Lab Clin Med 96:1054–1061
Kaplan JE, Saba TM (1981) Enhancement of reticuloendothelial activity by low-dose heparin during intravascular coagulation. J Reticuloendothel Soc 29:381–393
Keski-Oja J (1976) Polymerization of major surface-associated glycoprotein, fibronectin, in cultured fibroblasts. FEBS-Letters 71:325–329
Keski-Oja J, Mosher DF, Vaheri A (1976) Cross-linking of a major fibroblast surface-associated glycoprotein (fibronectin) catalyzed by blood coagulation factor XIII. Cell 9:29–35
Keski-Oja J, Mosher DF, Vaheri A (1977) Dimeric character of fibronectin, a major cell surface-associated glycoprotein. Biochem Biophys Res Commun 74:699–706
Keski-Oja J, Sen A, Todaro GJ (1980) Direct association of fibronectin and actin molecules in vitro. J Cell Biol 85:527–533
Keski-Oja J, Ruoslahti E, Engvall E (1981) Binding of fibronectin to actin is inhibited by gelatin. Biochem Biophys Res Commun 100:1515–1522
Klebe RJ (1974) Isolation of a collagen-dependent cell attachment factor. Natur 250:248–251
Kleinman HK, Martin GR, Fishman PH (1979) Ganglioside inhibition of fibronectin-mediated cell adhesion to collagen. Proc Natl Acad Sci USA 76:3367–3371
Kurkinen M, Vaheri A, Roberts PJ, Stenman S (1980) Sequential appearance of fibronectin and collagen in experimental granulation tissue. Lab Invest 43:47–51
Kuusela P, Ruoslahti E, Vaheri A (1975) Polypeptides of a glycoprotein antigen (SF) present in serum and surface of normal but not of transformed chicken fibroblasts. Biochem Biophys Acta 379:295–303
Kuusela P (1978) Fibronectin binds to staphylococcus aureus. Nature 276:718–720
Kuusela P, Vaheri A, Palo J, Ruoslahti E (1978) Demonstration of fibronectin in human cerebrospinal fluid. J Lab Clin Med 92:595–601
Labat-Robert J, Birembaut P, Adnet JJ, Mercantini F, Robert L (1980) Loss of fibronectin in human breast cancer. Cell Biology International Reports 4:609–616
Lanser ME, Saba TM, Scovill WA (1980) Opsonic glycoprotein (plasma fibronectin) levels after burn injury. Ann Surg 192:776–782
Lanser ME, Saba TM (1981) Fibronectin as a co-factor necessary for optimal granulocyte phagocytosis of staphylococcus aureus. J Reticuloendothel Soc 30:415–424
Lanser ME, Saba TM (1983) Correction of serum opsonic defects after burn and sepsis by opsonic fibronectin administration. Arch Surg 118:338–342
Laurell C-B (1972) Elektroimmunoassay. Scand J Clin Lab Invest 29 (Suppl 124):21–37
Linder E, Vaheri A, Ruoslahti E, Wartiovaara J (1975) Distribution of fibroblast surface antigen in the developing chick embryo. J Exp Med 142:41–49
Lloyd KO, Travassos LR, Takahashi T, Old LJ (1979) Cell surface glycoproteins of human tumor cell lines: Unusual characteristics of malignant melanoma. J Natl Cancer Inst 63:623–633
Macarak EJ, Kirby E, Kirk T, Kephalides NA (1978) Synthesis of cold-insoluble globulin by cultured calf endothelial cells. Proc Natl Acad Sci USA 75:2621–2625
Malik AB, van der Zee H (1978) Mechanism of pulmonary edema induced by microembolization in dogs. Circ Res 42:72–79
Mancini G, Carbonara AO, Heremans JF (1965) Immunochemical quantitation of antigens by single radial immunodiffusion. Immunochemistry 2:235–254
Marquette D, Molnar J, Yamada K, Schlesinger D, Darby S, van Alten P (1981) Phagocytosis-promoting activity of avian plasma and fibroblastic cell surface fibronectins. Mol Cell Biochem 36:147–155
Matsuda M., Saida T, Kasegawa R (1976) Cryofibrinogen in the plasma of patients with skin ulcerative lesions on the legs: A complex of fibrinogen and cold-insoluble globulin. Thromb Res 9: 541–552
Mayer JE jr, Kersten TE, Humphrey EW (1981) Effects of transfusion of emboli and aged plasma on pulmonary capillary permeability. J Thorac Cardiovasc Surg 82:358–364
McDonald JA, Baum BJ, Rosenberg DM, Kelman JA, Brin SC, Crystal RG (1979) Destruction of a major extracellular adhesive glycoprotein (fibronectin) of human fibroblasts by neutral proteases from polymorphonuclear leucocyte granules. Lab Invest 40:350–357
McDonald JA, Kelley DG (1980) Degradation of fibronectin by human leucocyte elastase: Release of biologically active fragments. J Biol Chem 255:8848–8858
Molnar J, Gelder FB, Lai MZ, Siefring GE, Credo BR, Lorand L (1979) Purification of opsonically active human and rat cold-insoluble globulin (plasma fibronectin). Biochemistry 18:3909–3916
Morrisson IR, Edsall JT, Miller SG (1948) Preparation and properties of serum and plasma proteins XVIII. The separation of purified fibrinogen from fraction I of human plasma. J Am Chem Soc 70:3103–3108
Mosher DF (1975) Cross-linking of cold-insoluble globulin by fibrin stabilizing factor. J Biol Chem 250:6614–6621
Mosher DF (1976) Action of fibrin-stabilizing factor on cold-insoluble globulin and alpha2-macroglobulin in clotting plasma. J Biol Chem 251:1639–1645
Mosher DF (1976) Changes in plasma cold-insoluble globulin concentration during experimental Rocky-Mountain spotted fever infection in Rhesus monkeys. Thromb Res 9:37–45
Mosher DF (1977) Labelling of a major fibroblast surface protein (fibronectin) catalyzed by blood coagulation factor XIII a. Biochem Biophys Acta 491:205–210
Mosher DF, Saksela O, Keski-Oja J, Vaheri A (1977) Distribution of a major surface-associated glycoprotein, fibronectin, in cultures of adherent cells. J Supramol Struct 6:551–557
Mosher DF, Vaheri A (1978) Thrombin stimulates the production and release of a major surface-associated glycoprotein (fibronectin) in cultures of human fibroblasts. Exp Cell Res 112:323–334
Mosher DF, Williams EM (1978) Fibronectin concentration is decreased in plasma of severely ill patients with disseminated intravascular coagulation. J Lab Clin Med 91:729–735
Mosher DF, Proctor RA (1980) Binding and factor XIIIa mediated cross-linking of a 27-kilodalton fragment of fibronectin to staphylococcus aureus. Science 209:927–928
Mosher DF, Schad PE, Vann JM (1980) Cross-linking of collagen and fibronectin by factor XIII a. J Biol Chem 255:1181–1188
Mosesson MW, Colman RW, Sherry S (1968) Chronic intravascular coagulation syndrome. Report of a case with special studies of an associated plasma cryoprecipitate (“cryofibrinogen”). N Engl J Med 278:815–821
Mosesson MW, Umfleet RA (1970) The cold-insoluble globulin of human plasma. I. Purification, primary characterization, and relationship to fibrinogen and other cold-insoluble fraction components. J Biol Chem 245:5728–5736
Mosesson MW, Chen AB, Huseby RM (1975) The cold-insoluble globulin of human plasma: Studies of its essential structural features. Biochem Biophys Acta 386:509–524
Murray JC, Liotta L, Rennard SI, Martin GR (1980) Adhesion characteristics of murine metastatic and non-metastatic tumor cells in vitro. Cancer Res 40:347–351
Myrvold HE (1980) Microembolism and pulmonary haemodynamics in the early phase of experimental septic shock. Acta Chir Scand Suppl 499:21–30
Neri A, Ruoslahti E, Nicolson GL (1981) Distribution of fibronectin on clonal cell lines of a rat mammary adenocarcinoma growing in vitro and in vivo at primary and metastatic sites. Cancer Res 41:5082–5095
Neuhof H, Seeger W, Wolf H, Roka L, Lasch HG (1982) Verbrauchskoagulopathie und Lungenfunktion. Internist 23:457–462
Niehaus GD, Schuhmacher PT, Saba TM (1980) Influence of opsonic fibronectin deficiency on lung fluid balance during bacterial sepsis. J Appl Physiol: Respirat Environ Exercise Physiol 49:693–699
Niemczuk P, Perkins RM, Talbot IC, Critchley DR (1982) Lack of correlation between metastasis of human rectal carcinoma and the absence of stromal fibronectin. Br J Cancer 45:500–505
Nishida T, Ohashi Y, Awata T, Manabe R (1983) Fibronectin — A new therapy for corneal trophic ulcer. Arch Ophthalmol 101:1046–1048
Oh E, Pierschbacher M, Ruoslahti E (1981) Deposition of plasma fibronectin in tissues. Proc Natl Acad Sci USA 78:3218–3222
Parsons RG, Aldenderfer PH, Kowal R (1979) Detection of a human serum DNA-binding protein associated with malignant disease. JNCI 63:43–47
Parsons RG, Todd HD, Kowal R (1979) Isolation and identification of a human serum fibronectin-like protein elevated during malignant disease. Cancer Res 39:4341–4345
Pearlstein E, Seaver J (1976) Non-lytic, non-ionic detergent extraction of plasma membrane constituents from normal and transformed fibroblasts. Biochem Biophys Acta 426:589–597
Pena SDJ, Hughes RC (1978) Fibroblast to substratum contacts mediated by the different forms of fibronectin. Cell Biology International Reports 2:339–344
Plow EF, Birdwell C, Ginsberg MH (1979) Identification and quantitation of platelet-associated fibronectin antigen. J Clin Invest 63:540–543
Postlethwaite AE, Keski-Oja J, Balian G, Kang AH (1981) Induction of fibroblast chemotaxis by fibronectin. J Exp Med 153:494–499
Pott G, Meyering M, Voss B, Karges HE, Sieber A (1980) Rapid determination of fibronectin by laser nephelometry. Fibronectin concentrations in plasma in human diseases, I. J Clin Chem Clin Biochem 18:893–895
Pott G, Lohmann J, Zündorf P, Gerlach U (1981) Vermindertes Fibronektin im Plasma bei Patienten mit Sepsis und Schock. Dtsch Med Wochenschr 106:532–534
Quaroni A, Isselbacher KJ, Ruoslahti E (1978) Fibronectin synthesis by epithelial crypt cells of rat small intestine. Proc Natl Acad Sci USA 75:5548–5552
Rennard SI, Crystal RG (1981) Fibronectin in human bronchopulmonary lavage fluid. J Clin Invest 69:113–122
Repesh LA, Fitzgerald TJ, Furcht LT (1982) Fibronectin involvement in granulation tissue and wound healing in rabbits. J Histochem Cytochem 30:351–358
Rinaldo JE, Rogers RM (1982) Adult respiratory-distress syndrome. Changing concepts of lung injury and repair. New Engl J Med 306:900–909
Robbins AB, Doran JE, Reese AC, Mansberger AR jr (1980) Cold insoluble globulin levels in operative trauma: serum depletion, wound sequestration, and biological activity: an experimental and clinical study. Am Surg 46:663–672
Robbins AB, Doran JE, Reese AC, Mansberger AR (1981) Clinical response to cold insoluble globulin replacement in a patient with sepsis and thermal injury. Am J Surg 142:636–638
Rosen JJ, Culp LA (1977) Morphology and cellular origins of substrate-attached material from mouse fibroblasts. Exp Cell Res 107:139–149
Ruoslahti E, Vaheri A, Kuusela P, Linder E (1973) Fibroblast surface antigen: A new serum protein. Biochem Biophys Acta 322:352–358
Ruoslahti E, Vaheri A (1974) Novel human serum protein from fibroblast plasma membrane. Nature 248:789–791
Ruoslahti E, Vaheri A (1975) Interaction of soluble fibroblast surface antigen with fibrinogen and fibrin. Identity with cold-insoluble globulin of human plasma. J Exp Med 141:497–501
Ruoslahti E, Vaheri A (1976) Immunological interspecies cross reaction of fibroblast surface antigen (fibronectin). Immunochemistry 13:639–642
Ruoslahti E, Vuento M, Engvall E (1978) Interaction of fibronectin with antibodies and collagen in radioimmunoassay. Biochem Biophys Acta 534:210–218
Ruoslahti E, Hayman EG, Engvall E (1980) Molecular interactions of fibronectin. Progr Clin biolog Res (TCSM) 41:821–828
Ruoslahti E (1981) Fibronectin. J Oral Pathol 10:3–13
Ruoslahti E, Hayman EG, Engvall E, Cothran WC, Butler WT (1981) Alignment of biologically active domains in the fibronectin molecule. J Biol Chem 256:7277–7281
Saba TM, Filkins JP, Di Luzio NR (1966) Properties of the “opsonic system” regulating in vitro hepatic phagocytosis. J Reticuloendothel Soc 3:398–414
Saba TM, Di Luzio NR (1969) Reticuloendothelial blockade and recovery as a function of opsonic activity. Am J Physiol 216:197–205
Saba TM (1970) Physiology and physiopathology of the reticuloendothelial system. Arch Intern Med 126:1031–1052
Saba TM (1975) Reticuloendothelial systemic host defense after surgery and traumatic shock. Circ Shock 2:91–108
Saba TM, Antikatzides TG (1976) Decreased resistance to intravenous tumor cell challenge during reticuloendothelial depression after surgery. Brit J Cancer 34:381–389
Saba TM, Cho E (1977) Alteration of tumor growth by a purified alpha-2-glycoprotein. J Reticuloendothel Soc 22:583–596
Saba TM, Cho E (1979) Reticuloendothelial systemic response to operative trauma as influenced by cryoprecipitate or cold-insoluble globulin therapy. J Reticuloendothel Soc 26:171–186
Saba TM, Cho E (1980) Reticuloendothelial (RE) response to surgery was modified by intravenous administration of plasma cryoprecipitate or cold-insoluble globulin (plasma fibronectin) purified by affinity chromatography. Adv Shock Res 3:251–271
Saba TM, Jaffe E (1980) Plasma fibronectin (opsonic glycoprotein): Its synthesis by vascular endothelial cells and role in cardiopulmonary integrity after trauma as related to reticuloendothelial function. Am J Med 68:577–594
Saba TM, Scovill WA, Powers SA (1980) Human host defense mechanisms as they relate to surgery and trauma. Surg Ann 12:1–20
Saba TM, Albert WH, Blumenstock FA, Evanega G, Staehler F, Cho E (1981) Evaluation of a rapid immunoturbidimetric assay for opsonic fibronectin in surgical and trauma patients. J Lab Clin Med 98:482–491
Schölmerich J, Volk BA, Köttgen E, Ehlers S, Gerok W (1982) Differentialdiagnose des Aszites mittels einfacher Laborparameter. Z Gastroenterol 20:517–518
Schweinburg FB, Fine J (1960) Evidence for a lethal endotoxemia as the fundamental feature of irreversibility in three types of traumatic shock. J Exp Med 112:793
Scott DL, Wainwright AC, Walton KW, Williamson N (1981) Significance of fibronectin in rheumatoid arthritis and osteoarthrosis. Ann Rheum Dis 40:142–153
Scovill WA, Saba TM, Kaplan JE, Bernard H, Powers S (1976) Deficits in reticuloendothelial humoral control mechanisms in patients after trauma. J Trauma 16:898–904
Scovill WA, Saba TM, Blumenstock FA, Bernard H, Powers SR (1978) Opsonic alpha-2-surface binding glycoprotein therapy during sepsis. Ann Surg 188:521–529
Scovill WA, Annest SJ, Saba TM, Blumenstock FA, Newell JC, Stratton HH, Powers SR (1979) Cardiovascular hemodynamics after opsonic alpha-2-surface binding glycoprotein therapy in injured patients. Surgery 86:284–293
Sekiguchi K, Hakomori S-I (1980) Functional domain structure of fibronectin. Proc Natl Acad Sci USA 77:2661–2665
Sherman LA, Lee J (1977) Specific binding of soluble fibrin to macrophages. J Exp Med 145:76–85
Sherman LA, Lee J (1982) Fibronectin: Blood turnover in normal animals and during intravascular coagulation. Blood 60:558–563
Shulman G (1979) Comparison of specific protein assays in biological fluids by radial immunodiffusion and laser nephelometer. Clin Biochem 12:123–125
Singer II (1982) Fibronexus formation is an early event during fibronectin-induced restoration of more normal morphology and substrate adhesion patterns in transformed hamster fibroblasts. J Cell Sci 56:1–20
Smith HS, Riggs JL, Mosesson MW (1979) Production of fibronectin by human epithelial cells in culture. Cancer Res 39:4138–4144
Smith LL, Veragut UP (1964) The liver and shock. Progr Surg 4:55–107
Snedeker PW, Kaplan JE, Saba TM (1979) Effect of intravascular coagulation on the vascular clearance of soluble fibrin monomer. Circ Shock 6:196–197
Snyder EL, Mosher DF, Hezzey A, Golenwsky G (1981) Effect of blood transfusion on in vivo levels of plasma fibronectin. J Lab Clin Med 98:336–341
Spicer D, Branton PE (1980) Reduction of cell surface fibronectin (LETS protein) correlates with tumorigenicity of hamster fibroblasts transformed by herpes simplex virus type 2. Intervirology 13:58–64
Stathakis NE, Mosesson MW (1977) Interaction among heparin, cold-insoluble globulin, and fibrinogen in formation of the heparin precipitable fraction of plasma. J Clin Invest 60:855–865
Stathakis NE, Mosesson MW, Chen AB, Galanakis DK (1978) Cryoprecipitation of fibrin-fibrinogen complexes induced by the cold-insoluble globulin of plasma. Blood 51:1211–1222
Stathakis NE, Fountas A, Tsianos E (1981) Plasma fibronectin in normal subjects and in various disease states. J Clin Pathol 34:504–508
Stau T, Metz J, Taugner R (1973) Exogenous35S-labelled heparin: Organ distribution and metabolism. Naunyn-Schmiedeberg's Arch Pharmacol 280:93–102
Stemberger A, Hörmann H (1976) Affinity chromatography on immobilized fibrinogen and fibrin monomer. II. The behaviour of cold-insoluble globulin. Hoppe-Seyler's Z Physiol Chem 357:1003–1005
Stenmann S, Wartiovaara J, Vaheri A (1977) Changes in the distribution of a major fibroblast protein, fibronectin, during mitosis and interphase. J Cell Biol 74:453–467
Stenmann S, Vaheri A (1978) Distribution of a major conective tissue protein, fibronectin, in normal human tissues. J Exp Med 147:1054–1064
Stenmann S, von Smitten K, Vaheri A (1980) Fibronectin and atherosclerosis. Acta Med Scand (Suppl) 642:165–170
Stone KR, Smith RE, Joklik WK (1974) Changes in membrane polypeptides that occur when chick embryo fibroblasts and NRK cells are transformed with avian sarcoma viruses. Virology 58:86–100
Todd HD, Coffee MS, Waalkes TP, Abeloff MD, Parsons RG (1980) Serum levels of fibronectin and a fibronectin-like DNA-binding protein in patients with various diseases. JNCI 65 (5):901–904
Tsukamoto Y, Helsel WE, Wahl SM (1981) Macrophage production of fibronectin, a chemoattractant for fibroblasts. J Immunol 127:673–678
Vaheri A, Ruoslahti E (1974) Disappearance of a major cell-type specific surface glycoprotein antigen (SF) after transformation of fibroblasts by Roux sarcoma virus. Int J Canc 13:579–586
Vaheri A, Ruoslahti E (1975) Fibroblast surface antigen produced but not retained by virus transformed human cells. J Exp Med 142:530–535
Vaheri A, Ruoslahti E, Westermark B, Ponten J, (1976) A common cell-type specific surface antigen in cultured human glial cells and fibroblasts: Loss in malignant cells. J Exp Med 143:64–72
Voss B, Allan S, Rauterberg J, Ullrich K, Gieselmann K, von Figura K (1979) Primary cultures of rat hepatocytes synthesize fibronectin. Biochem Biophys Res Commun 90:1348–1353
Vuento M, Wrann M, Ruoslahti E (1977) Similarity of fibronectins isolated from human plasma and spent fibroblast culture medium. FEBS Lett 82:227–231
Wartiovaara J, Leivo I, Virtanen I, Vaheri A (1978) Cell surface and extracellular matrix glycoprotein fibronectin. Expression in embryogenesis and in terato-carcinoma differentiation. Ann NY Acad Sci 312:132–141
Webb KS, Linn GH (1980) Urinary fibronectin potential as a biomarker in prostatic cancer. Investigative Urology 17:401–404
Wood G, Rucker M, Davis JW, Entwhistle R, Anderson B (1980) Interaction of plasma fibronectin with selected cryoglobulins. Clin Exp Immunol 40:358–364
Wright AE, Douglas SR (1903) An experimental investigation of the role of the body fluids in connection with phagocytosis. Proc Roy Soc 72:357–370
Yamada KM, Weston JA (1974) Isolation of a major cell surface glycoprotein from fibroblasts. Proc Natl Acad Sci USA 71:3492–3496
Yamada KM, Yamada SS, Pastan I (1976) Cell surface protein partially restores morphology, adhesiveness, and contact inhibition of movement to transformed fibroblasts. Proc Natl Acad Sci USA 73:1217–1221
Yamada KM, Schlesinger DH, Kennedy DW, Pastan I (1977) Characterization of a major fibroblast cell surface glycoprotein. Biochemistry 16:5552–5559
Yamada KM, Kennedy DW (1979) Fibroblast cellular and plasma fibronectin are similar but not identical. J Cell Biol 80:492–498
Zardi L, Cecconi C, Barbieri O, Carnemolla B, Picca M, Santi L (1979) Concentration of fibronectin in plasma of tumor-bearing mice and synthesis by Ehrlich ascites tumor cells. Cancer Res 39:3774–3779
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Klar, E., Heene, D.L. Fibronectin. Klin Wochenschr 62, 963–974 (1984). https://doi.org/10.1007/BF01728426
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01728426